Sprout Health

About Sprout Health

Sprout Health is a telehealth weight-loss provider founded in 2022 that offers both brand-name and compounded GLP-1 medications, with plans starting at 9 per month. The availability of FDA-approved brand medications like Ozempic and Wegovy alongside compounded alternatives theoretically gives patients more choice. However, Sprout Health’s operational record raises serious concerns that overshadow this flexibility.

In September 2025, the FDA issued a warning letter to Sprout Health regarding regulatory compliance violations. This is not a routine finding. FDA warning letters are reserved for significant issues and are a matter of public record. While the specific details of the letter should be reviewed by any prospective patient, the existence of such an enforcement action places Sprout Health in a category of elevated regulatory risk that very few competitors share. Our editorial team considers this the single most important data point in evaluating this provider.

The company’s third-party review profile reinforces these concerns. On Trustpilot, Sprout Health holds just a 2.6-star rating from approximately 20 reviews. While the sample size is small, a sub-3.0 rating is uncommon even among lower-tier providers and suggests systemic dissatisfaction among the patients who have left feedback. The F rating from the BBB compounds the picture, indicating a pattern of unresolved consumer complaints.

On the clinical side, Sprout Health offers low ongoing support with no notable lab integration, dietitian access, or structured follow-up protocols. For a provider that has attracted FDA scrutiny, the lack of robust clinical infrastructure is particularly concerning. Patients on GLP-1 medications benefit from periodic metabolic monitoring, and Sprout Health does not appear to prioritize this.

GLP-1.Reviews urges prospective patients to exercise significant caution with Sprout Health. The combination of an FDA warning letter, poor customer reviews, and an F BBB rating creates a risk profile that is difficult to recommend when numerous alternative providers exist at comparable or lower price points. Patients who are nonetheless interested should thoroughly research the FDA warning letter and confirm the current regulatory status of Sprout Health’s operations before enrolling.

Sprout Health GLP-1 Medications

At a Glance